United Kingdom: Food, Drugs, Healthcare, Life Sciences

The MHRA has launched a consultation on proposed updates to the definition of gene therapy medicinal products (“GTMPs”) under the UK Human Medicines Regulations 2012 (“HMRs”).

This podcast focuses on the pharmaceutical industry and, in particular, M&A activity in the sector and the recent surge in licensing deals involving Chinese biotechs.

Chris Packham is not a man known for backing down from a fight. Whether it's badgers, bird of prey persecution, or the BBC's...

The MHRA has launched a consultation on proposed updates to the definition of gene therapy medicinal products (“GTMPs”) under the UK Human Medicines Regulations 2012 (“HMRs”).

As set out in the EPO’s recently-released Technology Dashboard 2025 (its annual summary of key figures and trends in patent activity), growth in the field of battery technologies continues unabated, with the number...

This podcast focuses on the pharmaceutical industry and, in particular, M&A activity in the sector and the recent surge in licensing deals involving Chinese biotechs.

Personal injury claims increasingly involve significant mental health consequences, from anxiety and PTSD to depression and emotional distress. Understanding the complex relationship between physical trauma and psychological harm is essential for victims seeking proper support and compensation, particularly when psychiatric injuries occur alongside or independently of physical injuries.

The MHRA has launched a consultation on proposed updates to the definition of gene therapy medicinal products (“GTMPs”) under the UK Human Medicines Regulations 2012 (“HMRs”).

On 11 May 2026, the Medicines and Healthcare products Regulatory Agency (“MHRA”) opened a call for evidence on proposed changes to pre-market medical device and in vitro diagnostic medical device (“IVD”)...